Dr Nigel Brown Email and Phone Number
Dr Nigel Brown's Location
Princeton, New Jersey, United States, United States
Dr Nigel Brown's Contact Details
Dr Nigel Brown work email
- Valid
- Valid
- Valid
- Valid
- Valid
Dr Nigel Brown personal email
n/a
Dr Nigel Brown phone numbers
About Dr Nigel Brown
Specializing in business leadership, innovation, strategic planning, governance and M&A in the life sciences and high tech sectors. Experienced deal-maker ($10Bn+ in executed transactions), operator (full P&L, $100M+), with 20yrs C-Suite tenure at public Mid-Cap's, 10yrs in Private Equity, and a Board member at multiple public and private companies. Charity trustee for a number of schools, museums, arts and social services organizations.
Dr Nigel Brown's Current Company Details
Dr Nigel Brown Work Experience Details
-
Board MemberUniversal Display Corporation Mar 2024 - PresentEwing, New Jersey, UsUniversal Display Corporation (NASDAQ: OLED) is lighting up the organic light emitting diode (OLED) revolution with its proprietary OLED technologies and proprietary phosphorescent materials. The Company is a world-class IP innovator, technology developer, patent licensor and materials supplier for the rapidly growing OLED markets. We are a leader in developing and delivering state-of-the-art, OLED technologies, materials and services to the display and lighting industries.
-
Advisor - Rothschild & Co., Five Arrows Managers LlpRothschild & Co Jan 2024 - PresentParis, France, Fr -
Board MemberInotiv Nov 2021 - PresentWest Lafayette, In, UsAt Inotiv (NASDAQ: NOTV), our focus is clinical decision support for development of new medicines: We deliver a comprehensive and integrated range of preclinical safety assessment services, analysis, bioanalysis, and DMPK and consulting solutions essential to drug development success. -
Board MemberMolecular Designs Oct 2021 - PresentBirmingham, Al, UsMolecular Designs is a team of doctors and scientists working to advance molecular diagnostics. Our mission is to simplify the delivery of molecular technologies. We do this by developing, producing, and supplying multiplex assays for research use. We believe individualized molecular data is the foundation for understanding and diagnosing many diseases. -
Board MemberStreamline Scientific Oct 2021 - PresentBirmingham, Alabama, UsMolecular insights are often the deciding factor for patient management. Our solutions empower researchers and physicians with the best data, faster and more efficiently. Whether you need to equip and optimize an existing lab or establish a new lab, Streamline Scientific equips healthcare providers and researchers with solutions that lower cost, yield faster, more accurate insights—driving better-informed research and treatment decisions. -
Chief Executive OfficerPrinceton Healthcare Advisory Llc Sep 2015 - PresentFounder of Princeton Healthcare Advisory LLC, a specialty advisory firm supporting growth-focused private equity, venture capital and strategic investors in the healthcare and life sciences sectors.
-
Founder ShareholderMilestone Pharmaceuticals Inc. 2005 - PresentMontreal, Qc, CaMilestone Pharmaceuticals Inc. (NASDAQ: MIST) is a cardiovascular drug development company developing novel small molecule therapeutics based on clinically validated mechanisms. Milestone’s lead product is a novel and potent short-acting calcium channel antagonist for the systemic treatment of transient cardiovascular conditions such as supraventricular tachycardia. -
Board MemberLifeblood Corporation Jun 2016 - Dec 2024LifeBlood is a privately held company dedicated to the introduction of a revolutionary and proprietary diagnostic test for the early detection of multiple sclerosis.
-
Board MemberVorpal Technologies K.K. Mar 2022 - Sep 2024Chuo-Ku, Tokyo, JpVorpal was sold to IQVIA in 2024.Vorpal offers expertise in market assessment, clinical, regulatory and reimbursement services for medical device companies, enabling their successful entry into Japan. -
Board MemberMcra, Llc May 2021 - Sep 2024Washington, Dc, UsMCRA was sold to IQVIA in 2024.MCRA’s mission is to be the leading strategic advisory services firm and clinical research organization to the life sciences industry by collaborating, supporting, and providing integrated services to balance value creation with risk mitigation to achieve pre-commercial and post-commercial success for the total product lifecycle. -
Senior AdvisorArsenal Capital Partners Oct 2021 - Dec 2023New York, Ny, UsArsenal is a specialized private equity firm with what it believes are market-leading franchises in the industrials and healthcare sectors. The firm’s mission is to build high-growth, technology- and innovation-rich businesses that are strategically important in their markets and deliver value for all stakeholders. -
General Partner, Private EquityTrevi Health Capital Mar 2017 - Dec 2021Trevi Health Capital is a specialist investment firm that provides healthcare-focused alternative asset management through a variety of private equity funds on a global scale. We were founded in 2005 and have invested over $500 million in the healthcare sector. We provide private equity capital for growth stage and middle-market healthcare companies with emphasis on healthcare information technology, healthcare services and medical technology. The investment team combines experienced investment professionals and senior-level executives and entrepreneurs with proven track records in the healthcare sector. -
Editorial Advisory Board MemberDrug Discovery World 2000 - 2020London, GbDrug Discovery World is the multi-platform global voice for the drug discovery community. From research stage to clinical trials the brand covers the scientific and commercial process involved in getting a drug to market–research, target identification and validation, drug molecule identification, lead molecule optimisation, pre-clinical research, clinical trial authorisation and application, and clinical trials phase I and II. DDW readers learn how to turn science into business. -
Chairman Of The Board, Board MemberBioaxone Biosciences Inc. 2001 - Aug 2019Cambridge, Ma, UsServed as Chairmen and Board Member leading up to the successful out-licensing of the company’s lead asset, BA-210 for spinal cord injury, to Vertex Pharmaceutics (NASDAQ: VRTX) in 2015, and successful out-licensing of additional assets to Neurelis in 2020 for treatment of Cerebral Cavernous Malformation.BioAxone is a private biotechnology company focused on the development of innovative drugs to restore neurological function and improve quality of life after spinal cord injury and other forms of neurotrauma. Our lead product, Cethrin™, is a proprietary biologic drug designed to reduce paralysis after spinal cord injury. Phase I/IIa clinical results show that Cethrin holds promise for promoting meaningful recovery after spinal cord injury and safely advancing the road to repair. -
Fund AdvisorHealth Catalyst Capital Management Llc May 2016 - Feb 2019New York, Ny, UsHealth Catalyst Capital Management is a venture capital fund investing in high growth US- based Healthcare IT businesses focused in a few key themes, each with potential to achieve $1 billion enterprise value in new or disrupted markets globally -
Strategic AdvisorEnvigo ++++ 2017 - 2019Indianapolis, Indiana, UsStrategic Advisor to Envigo leading up to the successful sale of its Preclinical Services division to LabCorp (NYSE: LH) in 2019.Envigo provides the broadest range of research models and related services to the pharmaceutical and biotechnology industries, government, academia and other life science organizations. As the largest organization that is solely dedicated to providing research models and related products and services, we are committed to helping researchers realize the full potential of their critical R&D projects as we fulfill our mission to work together to build a healthier and safer world. -
Board MemberCytovas, Llc Jul 2016 - Dec 2018CytoVas, LLC is a clinical stage, in-vitro diagnostics (IVD) company developing advanced cell- and particle-based assays for evaluating cardiovascular health. Our products leverage proprietary sample preparation, high-content, ultra-sensitive flow cytometry and biocomputation to yield a signature fingerprint of a patient’s vascular health status. Our technology addresses a broad range of applications, including drug development, to assess cardiovascular efficacy and liabilities across all therapeutic drug classes, clinical trial design, to target optimal responders, limit adverse events and monitor cardiovascular responses to drug therapy, and companion diagnostics and for clinical diagnostics to facilitate cardiovascular risk stratification and treatment/prevention decision-making.
-
Strategic AdvisorVium Inc. Sep 2015 - Oct 2018San Mateo, Ca, UsStrategic Advisor to Vium, which was successfully sold to Recursion Pharma (NASDAQ: RXRX) in 2020. Vium is the leader in living informatics platforms, focused on applying advances in life sciences, digital technology and large-scale interpretive methods to living systems. Vium combines the latest in sensors, computer intelligence and biomedical science to help researchers get higher quality, more predictive data from preclinical studies. -
Board MemberMedavante-Prophase Jun 2016 - Jul 2017Hamilton, New Jersey, UsBoard Member and investor at MedAvante, leading up to its sale to WCG.MedAvante is the leading global provider of technology-enabled signal detection solutions in clinical trials of treatments for central nervous system (CNS) disorders with more than a decade of experience improving clinician-reported diagnostic and outcome measurements. -
Corporate Vice President; Member Of The Executive Committee; Head Of Corp. Development & StrategyCovance Inc. Jun 2006 - Aug 2015Princeton, New Jersey, UsCovance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with annual revenues greater than $2 billion, global operations in more than 30 countries, and more than 12,000 employees worldwide. Covance provides high-quality nonclinical, clinical, and commercialization services to pharmaceutical and biotechnology companies to help reduce the time and costs associated with drug development. We also offer laboratory testing services to the chemical, agrochemical and food industries and are a market leader in toxicology services, central laboratory services, discovery services, and a top global provider of Phase III clinical trial management services. -
Senior Vice President; Member Of The Executive Committee; Gm, Preclinical Dev, Cmc & RegulatoryMds Pharma Services 2000 - 2006King Of Prussia, Pennsylvania, UsMDS Pharma Services – The world's premier provider of innovative drug discovery and development solutions. We offer a full spectrum of world-class discovery, preclinical and clinical resources and expertise, strategically located around the world, to meet the needs of the global pharmaceutical and biotech industries. Our broad range of services is designed to increase the speed, precision and productivity of your drug discovery and development activities. -
Senior Vice President & General Manager, Drug Discovery & Preclinical Development ServicesPhoenix International Life Sciences Jan 1997 - May 2000SVP & GM at Phoenix International leading up to its sale to MDS Inc. in 2000.Phoenix International Life Sciences Inc. is one of the world's leading contract research organizations. The Company provides a wide spectrum of clinical, analytical, preclinical, drug discovery support and ancillary services to the pharmaceutical and biotechnology industries. Headquartered in Montreal, Quebec, the Company has operations throughout Europe and North America and research facilities in Australia, Israel and South Africa.
-
Scientific Advisory Board MemberAlgene Biotechnologies Jan 1997 - Dec 1998Algene Biotechnologies Corporation is active in the field of biomedical genetics as applied to the treatment of human diseases. Research and development activities focus on genes that cause Alzheimer disease, schizophrenia, migraine and Parkinson disease. -
Drug Metabolism & PharmacokineticsGsk 1993 - 1997Brentford, Middlesex, GbGSK is a science-led global healthcare company with a mission to help people do more, feel better, and live longer. Our goal is to be one of the world’s more innovative, best performing and most trusted healthcare companies. GSK has three global businesses that research, develop, and manufacture innovative pharmaceutical medicines, vaccines, and consumer healthcare products. -
Drug Metabolism & PharmacokineticsPfizer 1991 - 1993New York, New York, UsPfizer is an evolving company in a changing world. We've grown, in our 173 years, from a small family-owned business to a research-based pharmaceutical company that is now the world's largest and most valuable company devoted to healthcare.Our mission is to become the world's most valued company to patients, customers, colleagues, investors, business partners and the communities where we work and live.
Dr Nigel Brown Skills
Drug Metabolism
Mergers
Clinical Development
Biotechnology
Pharmaceutical Industry
Leadership
Clinical Trials
Lifesciences
Pharmacology
Strategic Planning
Cro
Management
Commercialization
Pharmacokinetics
Drug Discovery
Clinical Research
Mergers And Acquisitions
Drug Development
Life Sciences
Regulatory Affairs
Biopharmaceuticals
Pharmaceutics
Cross Functional Team Leadership
Gcp
Ctms
Immunology
Strategy
R&d
Business Strategy
Cro Management
Oncology
Dr Nigel Brown Education Details
-
University Of OxfordChemistry With Chemical Pharmacology -
University Of OxfordPhysiological Sciences (Metabolism And Pharmacology)
-
Massachusetts Institute Of TechnologyToxicology
-
The Open UniversityBusiness Administration
Frequently Asked Questions about Dr Nigel Brown
What company does Dr Nigel Brown work for?
Dr Nigel Brown works for Universal Display Corporation
What is Dr Nigel Brown's role at the current company?
Dr Nigel Brown's current role is CEO, Princeton Healthcare Advisory.
What is Dr Nigel Brown's email address?
Dr Nigel Brown's email address is nb****@****lth.com
What is Dr Nigel Brown's direct phone number?
Dr Nigel Brown's direct phone number is +160975*****
What schools did Dr Nigel Brown attend?
Dr Nigel Brown attended University Of Oxford, University Of Oxford, Massachusetts Institute Of Technology, The Open University.
What are some of Dr Nigel Brown's interests?
Dr Nigel Brown has interest in Arts And Culture, Health.
What skills is Dr Nigel Brown known for?
Dr Nigel Brown has skills like Drug Metabolism, Mergers, Clinical Development, Biotechnology, Pharmaceutical Industry, Leadership, Clinical Trials, Lifesciences, Pharmacology, Strategic Planning, Cro, Management.
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial